Buffered plate antigen test as a screening test for diagnosis of human brucellosis.
Brucellosis in Argentina is currently investigated in bank donor blood by the standard plate agglutination test (PAT). This study evaluated the buffered plate antigen test (BPA), now used to screen for bovine brucellosis, as a screen for human disease. Of 57 sera from patients with culture-confirmed brucellosis, 100% were detected with the BPA. Of 142 sera positive by rose bengal (RB) and complement fixation (CF), from patients with clinical evidence of brucellosis, the BPA detected 100%. Of 307 sera from a nonsymptomatic population that were RB and CF negative, the BPA detected 99.67% of the negative sera. The data indicate that the BPA is satisfactory compared to the other agglutination tests employed. It is an inexpensive and practical screening test and reduces the nonspecific reactions detected by the PAT.
Lucero
N E
NE
Instituto Nacional de Microbiología Dr. C.G. Malbrán, Buenos Aires, Argentina. NIDIA@IMPSATTI.COM.AR
Bolpe
J E
JE
D000328:Adult; D000942:Antigens, Bacterial / Q000276:immunology*; D002006:Brucellosis / Q000175:diagnosis* / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012698:Serologic Tests / Q000379:methods
D000942:Antigens, Bacterial